Janus Henderson Group PLC Lexicon Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.06 - $2.33 $355 - $780	335 Added 1.15%	29,470 $32,000
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $1,085 - $1,762	505 Added 1.76%	29,135 $66,000
Q1 2023 May 15, 2023	BUY	$1.99 - $2.68 $34,365 - $46,280	17,269 Added 152.0%	28,630 $69,000
Q2 2022 Aug 15, 2022	SELL	$1.31 - $2.69 $594 - $1,221	-454 Reduced 3.84%	11,361 $21,000
Q1 2022 May 16, 2022	BUY	$1.95 - $3.89 $56 - $112	29 Added 0.25%	11,815 $25,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.16 $44,904 - $72,601	11,786 New	11,786 $46,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $134M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.